Natco Pharma Launches Novel Fixed-Dose Combination Drug For Colorectal, Gastric Cancer

Natco Pharma on Thursday said it has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack
http://dlvr.it/SCnJxg